Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05243173
What this trial is testing

Biomarkers of Response to Systemic Treatments in FH-deficient RCC

Who this might be right for
MetabolomicsRenal Cell CarcinomaFH-Deficient RCC+1 more
RenJi Hospital 100
Not applicableLooking for participantsNCT07301827
What this trial is testing

Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03203473
What this trial is testing

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

Who this might be right for
Renal Cancer
Toni Choueiri, MD 85
Not applicableUnknownNCT04609293
What this trial is testing

Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking University First Hospital 30
Not applicableNo Longer AvailableNCT03896815
What this trial is testing

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

Incyte Corporation
Testing effectiveness (Phase 2)Looking for participantsNCT07615348
What this trial is testing

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Ended earlyNCT00100685
What this trial is testing

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell CarcinomaMetastases
Abbott 48
Testing effectiveness (Phase 2)Study completedNCT00003968
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)WithdrawnNCT04648826
What this trial is testing

Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies

Who this might be right for
SarcomasMelanomasGerm Cell Tumors+2 more
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT03086174
What this trial is testing

Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma

Who this might be right for
Kidney Cancer Stage IvAdvanced Melanoma
Shanghai Junshi Bioscience Co., Ltd. 24
Not applicableStudy completedNCT02150148
What this trial is testing

Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors

Who this might be right for
Cancer
University of Alabama at Birmingham 46
Early research (Phase 1)Study completedNCT00581815
What this trial is testing

Spectroscopy With Surface Coils and Decoupling

Who this might be right for
Adrenal Cortical CancerBrain CancerBreast Cancer+16 more
Memorial Sloan Kettering Cancer Center 582
Not applicableEnded earlyNCT02131376
What this trial is testing

Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy

Who this might be right for
Renal Cell Carcinoma
Indiana University 26
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00494091
What this trial is testing

Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Pfizer 82
Very early researchActive Not RecruitingNCT02210117
What this trial is testing

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 104
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00421512
What this trial is testing

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Who this might be right for
Metastatic Renal Cell CarcinomaKidney Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01158534
What this trial is testing

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Renal Cell CancerStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 17
Next Page